• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情:阿育吠陀干预的务实计划

COVID-19 pandemic: A pragmatic plan for ayurveda intervention.

作者信息

Rastogi Sanjeev, Pandey Deep Narayan, Singh Ram Harsh

机构信息

Dept of Kaya Chikitsa, State Ayurvedic College and Hospital, Lucknow, 226003, India.

Department of Environment/Forests, Government of Rajasthan, Secretariat, Jaipur, 302005, Rajasthan, India.

出版信息

J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100312. doi: 10.1016/j.jaim.2020.04.002. Epub 2020 Apr 23.

DOI:10.1016/j.jaim.2020.04.002
PMID:32382220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177084/
Abstract

World community is facing an unprecedented pandemic of novel corona virus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Corona virus 2 (SARS-CoV- 2). The disease has spread globally with more than 1.43 million confirmed cases and 82,100 deaths as of April 8, 2020. Despite worldwide efforts to contain it, the pandemic is continuing to spread for want of a clinically-proven prophylaxis and therapeutic strategy. The dimensions of pandemic require an urgent harnessing of all knowledge systems available globally. Utilization of Traditional Chinese Medicine in Wuhan to treat COVID-19 cases sets the example demonstrating that traditional health care can contribute to treatment of these patients successfully. Drawing on the Ayurveda classics, contemporary scientific studies, and experiential knowledge on similar clinical settings, here we propose a pragmatic plan for intervention in India. We provide a plan for graded response, depending on the stage of infection among individuals, in a population. Notwithstanding the fact that no system of medicine has any evidence-based treatment for COVID-19 as yet, clinical interventions are required to be put in place. Therefore, pragmatic strategy proposed here for Ayurveda system of medicine requires immediate implementation. It will facilitate learning, generate evidence and shall be a way forward.

摘要

国际社会正面临由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型冠状病毒病(COVID-19)这一前所未有的大流行。截至2020年4月8日,该疾病已在全球传播,确诊病例超过143万例,死亡82100例。尽管全球都在努力控制疫情,但由于缺乏经临床验证的预防和治疗策略,大流行仍在继续蔓延。这场大流行的规模要求紧急利用全球所有可用的知识体系。武汉利用中医药治疗COVID-19病例树立了榜样,表明传统医疗保健可以成功地为这些患者的治疗做出贡献。借鉴阿育吠陀经典、当代科学研究以及类似临床环境的经验知识,在此我们为印度提出一项务实的干预计划。我们根据人群中个体的感染阶段提供了一个分级应对计划。尽管事实上尚无任何医学体系对COVID-19有循证治疗方法,但仍需要实施临床干预措施。因此,这里为阿育吠陀医学体系提出的务实策略需要立即实施。这将有助于学习、产生证据,并且是前进的方向。

相似文献

1
COVID-19 pandemic: A pragmatic plan for ayurveda intervention.新冠疫情:阿育吠陀干预的务实计划
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100312. doi: 10.1016/j.jaim.2020.04.002. Epub 2020 Apr 23.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A new era for nuclear medicine.核医学的新时代。
Hell J Nucl Med. 2020 Jan-Apr;23(1):2-3. doi: 10.1967/s002449912013.
4
Application of a Non-Linear multi-model Ayurveda Intervention in elderly COVID-19 patients- a retrospective case series.非线性多模型阿育吠陀干预在老年新冠肺炎患者中的应用——一项回顾性病例系列研究
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100476. doi: 10.1016/j.jaim.2021.06.016. Epub 2021 Jul 2.
5
Tuberculosis结核病
6
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.新型冠状病毒肺炎(COVID-19)中西医治疗进展:一篇叙述性综述
J Thorac Dis. 2020 Oct;12(10):6054-6069. doi: 10.21037/jtd-20-1810.
9
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
10
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病(COVID-19)?对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.

引用本文的文献

1
Safety and Efficacy of the Ayurvedic Formulation Guduchi Ghana Vati as a Preventive Remedy in COVID-19.印度草医学配方古杜奇加纳瓦蒂作为COVID-19预防药物的安全性和有效性
Cureus. 2024 Apr 23;16(4):e58807. doi: 10.7759/cureus.58807. eCollection 2024 Apr.
2
Ayurvedic and Chinese Herbs against Coronaviruses.草药对抗冠状病毒:阿育吠陀和中药。
Curr Pharm Des. 2024;30(21):1681-1698. doi: 10.2174/0113816128269864231112094917.
3
When is industry 'sustainable'? The economics of institutional variety in a pandemic.行业何时“可持续”?大流行中制度多样性的经济学。
Rev Evol Polit Econ. 2023 Apr 24:1-33. doi: 10.1007/s43253-023-00093-y.
4
Aptamer-Based Strategies to Address Challenges in COVID-19 Diagnosis and Treatments.基于适配体的策略应对新冠病毒疾病诊断与治疗中的挑战
Interdiscip Perspect Infect Dis. 2023 Jul 31;2023:9224815. doi: 10.1155/2023/9224815. eCollection 2023.
5
Perspective Toward Complementary & Alternative Medicines in the Prevention of COVID-19 Infection.关于补充和替代医学在预防新冠病毒感染方面的观点
Indian J Community Med. 2023 May-Jun;48(3):401-406. doi: 10.4103/ijcm.ijcm_282_22. Epub 2023 May 30.
6
The clinical evaluation of Basti along with Rasayana on symptoms of post-COVID-19 syndrome: an open-labeled proof of concept pragmatic study-a study protocol.巴斯蒂疗法联合rasayana疗法对新冠后综合征症状的临床评估:一项开放标签的概念验证实用性研究——研究方案
Pilot Feasibility Stud. 2023 Jun 3;9(1):92. doi: 10.1186/s40814-023-01322-1.
7
In silico screening, ADMET analysis and MD simulations of phytochemicals of Wall. as SARS CoV-2 inhibitors.作为严重急性呼吸综合征冠状病毒2(SARS CoV-2)抑制剂的Wall.植物化学成分的计算机模拟筛选、ADMET分析和分子动力学模拟
3 Biotech. 2023 Jul;13(7):221. doi: 10.1007/s13205-023-03635-7. Epub 2023 May 31.
8
A Brief Review on Medicinal Plants-At-Arms against COVID-19.药用植物对抗新冠病毒的简要综述
Interdiscip Perspect Infect Dis. 2023 Apr 24;2023:7598307. doi: 10.1155/2023/7598307. eCollection 2023.
9
Transmission dynamics and baseline epidemiological parameter estimates of Coronavirus disease 2019 pre-vaccination: Davao City, Philippines.2019 年冠状病毒病疫苗接种前的传播动态和基本流行病学参数估计:菲律宾达沃市。
PLoS One. 2023 Apr 7;18(4):e0283068. doi: 10.1371/journal.pone.0283068. eCollection 2023.
10
Herbal supplements as treatment options for COVID-19: A call for clinical development of herbal supplements for emerging and re-emerging viral threats in Sub-Saharan Africa.草药补充剂作为治疗新冠肺炎的选择:呼吁对撒哈拉以南非洲新出现和再次出现的病毒威胁进行草药补充剂的临床开发。
Sci Afr. 2023 Jul;20:e01627. doi: 10.1016/j.sciaf.2023.e01627. Epub 2023 Mar 5.

本文引用的文献

1
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
2
Threats and challenges of emerging viral diseases and scope of Ayurveda in its prevention.新兴病毒性疾病的威胁与挑战以及阿育吠陀在其预防中的作用范围
Ayu. 2019 Apr-Jun;40(2):67-68. doi: 10.4103/ayu.AYU_18_20. Epub 2020 Mar 20.
3
Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis.阿育吠陀和瑜伽预防新冠病毒的公共卫生方法
J Altern Complement Med. 2020 May;26(5):360-364. doi: 10.1089/acm.2020.0129. Epub 2020 Apr 20.
4
COVID-19: what has been learned and to be learned about the novel coronavirus disease.新型冠状病毒病(COVID-19):对新型冠状病毒疾病的认识与探索。
Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. doi: 10.7150/ijbs.45134. eCollection 2020.
5
Activating Immunity to Fight a Foe - A New Path.激活免疫力对抗敌人——一条新途径。
N Engl J Med. 2020 Mar 26;382(13):1270-1272. doi: 10.1056/NEJMcibr1917242.
6
Epidemiological data from the COVID-19 outbreak, real-time case information.新冠疫情流行病学数据,实时病例信息。
Sci Data. 2020 Mar 24;7(1):106. doi: 10.1038/s41597-020-0448-0.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China.成功遏制新冠病毒:世卫组织关于中国新冠疫情的报告。
Infection. 2020 Apr;48(2):151-153. doi: 10.1007/s15010-020-01409-4.
9
Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.睡茄(L.)邓纳尔:癌症治疗的潜在辅助剂。
J Ethnopharmacol. 2020 Jun 12;255:112759. doi: 10.1016/j.jep.2020.112759. Epub 2020 Mar 12.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.